Status: retired, Primitive. Date: 31-Mar 2019. Module: SNOMED Clinical Terms Australian extension
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3193471000168118 | Tildrakizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 3193481000168115 | Tildrakizumab | en | Synonym | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tildrakizumab | Is a | Monoclonal antibody | false | Inferred relationship | Some | ||
| Tildrakizumab | Is a | Interleukin receptor antagonist | false | Inferred relationship | Some | ||
| Tildrakizumab | Has disposition | Interleukin receptor antagonist | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
SAME AS association reference set
FHIR